Author(s): Shaikh Sohel, M. Najmuddin, Hariprasanna R. C., Kishore V. C.

Email(s): Email ID Not Available

DOI: Not Available

Address: Shaikh Sohel*, M. Najmuddin, Hariprasanna R. C., Kishore V. C.
Department of Pharmaceutics, RMES’S College of Pharmacy, Gulbarga
*Corresponding Author

Published In:   Volume - 6,      Issue - 8,     Year - 2013


ABSTRACT:
The aim of the study was to develop orally disintegrating tablet for Juvenile rheumatoid arthritis. Celecoxib is used to the relief of sign and symptoms of Juvenile rheumatoid arthritis. In present work an attempt has been made to prepared orally disintegrating tablet using Celecoxib by direct compression method. The tablets were prepared by using superdisintegrants such as croscarmellose sodium, crospovidone, sodium starchglycolate in different ratio and evaluated for hardness, weight variation, friability, wetting time, disintegration time, drug content and In vitro dissolution study. Drug-exipient compatibility was done by FTIR and DSC studies. Formulation CCP3 prepared dy direct compression method containing 10% crospovidone showed 92.09% of drug release in 30 minute.


Cite this article:
Shaikh Sohel, M. Najmuddin, Hariprasanna R. C., Kishore V. C. Development and Evaluation of Orally Disintegrating Tablet of Celecoxib for Juvenile Rheumatoid Arthritis. Research J. Pharm. and Tech. 6(8): August 2013; Page 865-867.

Cite(Electronic):
Shaikh Sohel, M. Najmuddin, Hariprasanna R. C., Kishore V. C. Development and Evaluation of Orally Disintegrating Tablet of Celecoxib for Juvenile Rheumatoid Arthritis. Research J. Pharm. and Tech. 6(8): August 2013; Page 865-867.   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2013-6-8-18


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available